IL6 and Insulin resistance: Recent evidence shows that IL-6 may have a possible disease-limiting role in liver inflammation and remodeling through the induction of miR-223 secretion by myeloid cells [93], insulin resistance, and adipose tissue macrophage accumulation in animal models [92].